PCOS病人血清抗苗勒管激素与卵巢过度刺激综合征的关系被引量：3

THE CORRELATION BETWEEN AMH IN SERUM AND OHSS IN PCOS PATIENTS

下载PDF

导出

摘要目的探讨多囊卵巢综合征(PCOS)病人血清抗苗勒管激素(AMH)与卵巢过度刺激综合征(OHSS)的关系。方法选取于我院行常规长方案治疗的PCOS病人共71例,根据是否发生OHSS分为中重度OHSS组(A组)和轻度及未发生OHSS组(B组)。应用ELISA法检测两组病人基础血清AMH和降调后血清AMH水平。结果 PCOS病人基础血清AMH水平与降调后相比,差异无显著性。A组病人基础血清及降调后血清AMH水平均显著高于B组(t=2.00、3.28,P<0.05)。PCOS病人基础血清AMH水平与人绒毛膜促性腺激素(HCG)日的雌二醇(E2)水平及大卵泡数(≥14mm)均呈显著正相关(r=0.341、0.250,P<0.05)。结论 PCOS病人基础血清AMH水平与OHSS的发生存在显著相关性,AMH可能成为预测OHSS的新指标。 Objective To explore the correlation between serum anti-Mullerian hormone（AMH）and ovarian hyperstimulation syndrome（OHSS）in patients with polycystic ovary syndrome（PCOS）. Methods This study consisted of 71 patients with PCOS treated in our hospital with routine program.According to if OHSS was developed,the patients were divided into group A-moderate-severe OHSS;group B-mild or without OHSS.Using ELISA,baseline and after down-regulation serum AMH levels were detected. Results The difference was not statistically significant between the basic serum levels of AMH and that after down-regulation in patients with PCOS.The basic and after down-regulation levels of serum AMH in group A were higher than that in group B（t=2.00,3.28;P0.05）.The basic serum AMH levels in PCOS patients were positively correlated with E2 levels and the mean number of follicles≥ 14 mm on HCG day（r=0.341,0.250;P0.05）. Conclusion The basic serum levels of AMH in patients with polycystic ovary syndrome are obviously associated with the development of ovarian hyperstimulation syndrome,AMH may become a new predictor for this condition.

作者孙娜祁秀娟吕映频刘建新刘海宁汤秀明

机构地区青岛大学附属医院生殖医学科

出处《青岛大学医学院学报》 CAS 2015年第4期471-473,476,共4页 Acta Academiae Medicinae Qingdao Universitatis

关键词卵巢过度刺激综合征多囊卵巢综合征抗苗勒管激素 ovarian hyperstimulation syndrome polycystic ovary syndrome anti-Mullerian hormone

分类号 R711.75 [医药卫生—妇产科学]

引文网络
相关文献

参考文献9

1JAYAPRAKASAN K, CAMPBELL B, HOPKISSON J, et al. A prospective, comparative analysis of anti-Mtillerian hor- mone, inhibin-B, and three-dimensional ultrasound determi- nants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation [Jl. Fertility and Sterility, 2010,93(3) : 855-864.
2BROER S L, VAN DISSELDORP J, BROEZE K A, et al. Added vaiue of ovarian reserve testing on patient characteris- tics in the prediction o[ ovarian response and ongoing pregnan cy: an individual patient data approach[J]. Human Reproduc- tion Update, 2012,19(1) :26-36.
3王春哓,祁秀娟,刘海宁,刘建新,汤秀明.亮丙瑞林和曲普瑞林对体外受精-胚胎移植效果比较[J].齐鲁医学杂志,2014,29(2):112-114. 被引量：5
4JAYAPRAKASAN K, CAMPBELL B K, HOPKISSON J F, et al. Effect of pituitary desensitization on the early growing follieular cohort estimated using anfi-Muller an hormone[J], Human Reproduction (Oxford, England), 2008, 23 (11) 2577-2583 476.
5SEIFER D B, MACLAUGHLIN D T, PENZIAS A S, et al. Gonadotropin-releasing hormone agonist-induced differences in granulosa eell cycle kinetics are associated with alterations in follicular fluid mtillerianqnhibiting substance and androgen content[J]. The Journal o{ Clinical Endoerinol.ogy and Meta- bolism, 1993,76(3) :711-714.
6MOHAMED K A, DAVIES W A, LASHEN H. Antimt:lle rian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate[J]. Fertility and Steri- lity, 2006,86(5) :1515-1517.
7叶云,吴日然,林晓丽,廖月婵,杜彦,吴嘉齐,林秀峰,杜静.促性腺激素释放激素激动剂降调节对血清抗苗勒管激素的影响[J].中山大学学报（医学科学版）,2013,34(4):578-584. 被引量：6
8NARDO L G, GELBAYA T A, WILKINSON H, et al. Cir- culating basal anti Miillerian hormone levels as predictor of o- varian response in women undergoing ovarian stimulation for in vitro fertilization[J]. Fertility and Sterility, 2009,92 (5) 1586-1593.
9LEE T H, LIU C H, HUANG C C, et al. Serum anti- Miillerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles[J]. Human Reproduction (Oxford, England), 2008,23 (1) :160-167.

二级参考文献25

1林碧莲,耿方明,金鑫.醋酸亮丙瑞林临床应用评价[J].中国处方药,2005,4(9):59-60. 被引量：12
2郭方,徐丛剑.子宫内膜异位症药物治疗研究进展[J].中国妇幼健康研究,2006,17(6):510-513. 被引量：6
3Ye Y,Wu R,Ou J.Prediction of ovarian response on AMH concentrations before and after pituitary down-regulation in COH[J].Hum Reprod (Abstract book),2010,25(1):i310-i310.
4Jayaprakasan K,Campbell BK,Hopkisson JF,et al.Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone[J].Hum Reprod,2008,23 (11):2577-2583.
5Popovic-Todorovic B,Loft A,Lindhard A,et al.A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH.A suggestion for a recombinant FSH dosage normogram[J].Hum Reprod,2003,18 (4):781-787.
6Ficicioglu C,Kutlu T,Baqlam E,et al.Early follicular anti-Müllerian hormone as an indicator of ovarian reserve[J].Fertil Steril,2006,85(3):592-596.
7La Marca A,Sighinolfi G,Radi D,et al.AntiMullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)[J].Hum Reprod Update.2010,16(2):113-130.
8Seifer DB,MacLaughlin DT,Penzias AS,et al.Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content[J].Clin Endocrinol Metab,1993,76(3):711-714.
9van Rooij IA,Broekmans1 FT,Velde1 ER,et al.Serum anti-Mu¨ llerian hormone levels:a novel measure of ovarian reserve[J].Hum Reprod,2002,17 (12):3065-3071.
10Pe(n)arrubia J,Fábregues F,Manau D,et al.Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonistgonadotropin treatment[J].Hum Reprod,2005,20(4):915-922.